Literature DB >> 23271436

Subcellular localization of full-length human myeloid leukemia factor 1 (MLF1) is independent of 14-3-3 proteins.

Manuela Molzan1, Christian Ottmann.   

Abstract

Myeloid leukemia factor 1 (MLF1) is associated with the development of leukemic diseases such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, information on the physiological function of MLF1 is limited and mostly derived from studies identifying MLF1 interaction partners like CSN3, MLF1IP, MADM, Manp and the 14-3-3 proteins. The 14-3-3-binding site surrounding S34 is one of the only known functional features of the MLF1 sequence, along with one nuclear export sequence (NES) and two nuclear localization sequences (NLS). It was recently shown that the subcellular localization of mouse MLF1 is dependent on 14-3-3 proteins. Based on these findings, we investigated whether the subcellular localization of human MLF1 was also directly 14-3-3-dependent. Live cell imaging with GFP-fused human MLF1 was used to study the effects of mutations and deletions on its subcellular localization. Surprisingly, we found that the subcellular localization of full-length human MLF1 is 14-3-3-independent, and is probably regulated by other as-yet-unknown proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271436      PMCID: PMC6275728          DOI: 10.2478/s11658-012-0044-1

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  36 in total

1.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

Review 2.  14-3-3 proteins in the nervous system.

Authors:  Daniela Berg; Carsten Holzmann; Olaf Riess
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

3.  Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesis.

Authors:  Christian Ottmann; Lubna Yasmin; Michael Weyand; Jeffrey L Veesenmeyer; Maureen H Diaz; Ruth H Palmer; Matthew S Francis; Alan R Hauser; Alfred Wittinghofer; Bengt Hallberg
Journal:  EMBO J       Date:  2007-01-18       Impact factor: 11.598

4.  Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling.

Authors:  Manuela Molzan; Benjamin Schumacher; Corinna Ottmann; Angela Baljuls; Lisa Polzien; Michael Weyand; Philipp Thiel; Rolf Rose; Micheline Rose; Philipp Kuhenne; Markus Kaiser; Ulf R Rapp; Jürgen Kuhlmann; Christian Ottmann
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

5.  Characterization of a Drosophila homologue of the human myelodysplasia/myeloid leukemia factor (MLF).

Authors:  K Ohno; Y Takahashi; F Hirose; Y H Inoue; O Taguchi; Y Nishida; A Matsukage; M Yamaguchi
Journal:  Gene       Date:  2000-12-30       Impact factor: 3.688

6.  Bioinformatic and experimental survey of 14-3-3-binding sites.

Authors:  Catherine Johnson; Sandra Crowther; Margaret J Stafford; David G Campbell; Rachel Toth; Carol MacKintosh
Journal:  Biochem J       Date:  2010-03-15       Impact factor: 3.857

7.  The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family.

Authors:  H Fu; J Coburn; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.

Authors:  Noriko Yoneda-Kato; Jun-Ya Kato
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

9.  Myeloid Leukemia Factor 1 inhibits erythropoietin-induced differentiation, cell cycle exit and p27Kip1 accumulation.

Authors:  Louise Natalie Winteringham; Simon Kobelke; James Howard Williams; Evan Ingley; Svend Peter Klinken
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

10.  Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms.

Authors:  Sridharan Rajagopalan; Robert S Sade; Fiona M Townsley; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2009-11-20       Impact factor: 16.971

View more
  1 in total

1.  Identification of novel diagnostic biomarkers for thyroid carcinoma.

Authors:  Xiliang Wang; Qing Zhang; Zhiming Cai; Yifan Dai; Lisha Mou
Journal:  Oncotarget       Date:  2017-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.